Related references
Note: Only part of the references are listed.Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel Stealth Zinc(II) Complex?
Mahendiran Dharmasivam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series
Tharushi P. Wijesinghe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer
Faten Shehadeh-Tout et al.
PHARMACOLOGICAL RESEARCH (2023)
Human serum albumin as a copper source for anticancer thiosemicarbazones
Martin Schaier et al.
METALLOMICS (2023)
The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells
Mahendiran Dharmasivam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2022)
Copper-Catalyzed Glutathione Oxidation is Accelerated by the Anticancer Thiosemicarbazone Dp44mT and Further Boosted at Lower pH
Enrico Falcone et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Competition between reactive adsorption desulfurization and olefin hydrogenation over the NiO/ZnO-Al2O3-SiO2 adsorbent
Feng Ju et al.
NEW JOURNAL OF CHEMISTRY (2022)
Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma
Bekesho Geleta et al.
FASEB JOURNAL (2021)
Cyclodesulfurization: An Enabling Protocol for Synthesis of Various Heterocycles
Manasa Kadagathur et al.
CHEMISTRYSELECT (2021)
Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc
Tharushi P. Wijesinghe et al.
PHARMACOLOGICAL RESEARCH (2021)
Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC
Sundus N. Maqbool et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Synthesis and X-ray crystal structures of three new nickel(II) complexes of benzoylhydrazones: Catalytic applications in the synthesis of 2-arylbenzoxazoles
Samaresh Layek et al.
INORGANICA CHIMICA ACTA (2020)
High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones
Sonja Hager et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance
Syer C. Lim et al.
FASEB JOURNAL (2020)
Reactivity of Cu(ii)-, Zn(ii)- and Fe(ii)-thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation
Alice Santoro et al.
METALLOMICS (2019)
Novel Mechanism of Cytotoxicity for the Selective Selenosemicarbazone, 2-Acetylpyridine 4,4-Dimethyl-3-selenosemicarbazone (Ap44mSe): Lysosomal Membrane Permeabilization
Zaynab Al-Eisawi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics
Danuta S. Kalinowski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
Zhu-Ling Guo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Kinetico-mechanistic studies on methemoglobin generation by biologically active thiosemicarbazone iron(III) complexes
Maram T. Basha et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Zinc(II)-Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity
Alexandra E. Stacy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Activity Relationships of Di-2-pyridylketone, 2-Benzoylpyridine, and 2-Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance
Alexandra E. Stacy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The rational design of specific SOD1 inhibitors via copper coordination and their application in ROS signaling research
Xiongwei Dong et al.
CHEMICAL SCIENCE (2016)
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
Nicole A. Seebacher et al.
CELL DEATH & DISEASE (2016)
Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp)
Patric J. Jansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Antibacterial, antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones
Elena Pahontu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization
Christian Stefani et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the Triad of Death in cancer by Di-2-pyridylketone thiosemicarbazones
Patric J. Jansson et al.
PHARMACOLOGICAL RESEARCH (2015)
Improving the Alkaline Stability of Imidazolium Cations by Substitution
Huilong Dong et al.
CHEMPHYSCHEM (2014)
The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway
Jiabei Wang et al.
ONCOTARGET (2014)
Novel Chelators for Cancer Treatment: Where Are We Now?
Angelica M. Merlot et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Desulfurization processes of thiosemicarbazonecopper(II) derivatives in acidic and basic aqueous media
Ruben Gil-Garcia et al.
NEW JOURNAL OF CHEMISTRY (2013)
Structure-activity studies of 4-phenyl-substituted 2′-benzoylpyridine thiosemicarbazones with potent and selective anti-tumour activity
Adeline Y. Lukmantara et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
N-myc downstream regulated gene 1 modulates Wnt-ß-catenin signalling and pleiotropically suppresses metastasis
Wen Liu et al.
EMBO MOLECULAR MEDICINE (2012)
Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo
David B. Lovejoy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
Patricia Quach et al.
MOLECULAR PHARMACOLOGY (2012)
Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
David B. Lovejoy et al.
CANCER RESEARCH (2011)
Halogenated 2′-Benzoylpyridine Thiosemicarbazone (XBpT) Chelators with Potent and Selective Anti-Neoplastic Activity: Relationship to Intracellular Redox Activity
Christian Stefani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A phase II trial of TriapineA® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503
Anne M. Traynor et al.
INVESTIGATIONAL NEW DRUGS (2010)
Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity
Patric J. Jansson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells
V. Ashutosh Rao et al.
CANCER RESEARCH (2009)
Iron Chelators of the Dipyridylketone Thiosemicarbazone Class: Precomplexation and Transmetalation Effects on Anticancer Activity
Paul V. Bemhardt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
2-Acetylpyridine Thiosemicarbazones are Potent Iron Chelators and Antiproliferative Agents: Redox Activity, Iron Complexation and Characterization of their Antitumor Activity
Des R. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors
Yu Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Increasing the antibacterial activity of gallium(III) against Pseudomonas aeruginosa upon coordination to pyridine-derived thiosemicarbazones
Jeferson G. da Silva et al.
POLYHEDRON (2009)
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects:: Cellular iron chelation mediating cytotoxic activity
Veronika Opletalova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Brigette Ma et al.
INVESTIGATIONAL NEW DRUGS (2008)
Phase II study of triapinea® in patients with metastatic renal cell carcinoma:: A trial of the national cancer institute of canada clinical trials group (NCIC IND.161)
Jennifer J. Knox et al.
INVESTIGATIONAL NEW DRUGS (2007)
Future of toxicology-iron chelators and differing modes of action and toxicity: The changing face of iron chelation therapy
Danuta S. Kalinowski et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
A turn-on fluorescent sensor for selective Hg(II) detection in aqueous media based on metal-induced dye formation
Yonggang Zhao et al.
INORGANIC CHEMISTRY (2006)
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
Des R. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
Megan Whitnall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski et al.
PHARMACOLOGICAL REVIEWS (2005)
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan et al.
BLOOD (2004)
The role of iron in cell cycle progression and the proliferation of neoplastic cells
NTV Le et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2002)
The iron metabolism of neoplastic cells: alterations that facilitate proliferation?
JC Kwok et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Evidence of desulfurization in the oxidative cyclization of thiosemicarbazones.: Conversion to 1,3,4-oxadiazole derivatives
P Gómez-Saiz et al.
INORGANIC CHEMISTRY (2002)
Biological activity of complexes derived from pyridine-2-carbaldebyde thiosemicarbazone -: Structure of [Co(C7H7N4S)2][NCS]
J García-Tojal et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2001)
Share Paper
